4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-22-004152
Chief Patient Supply Officer sold 4,846 shares at an average $3.55 ($17,222)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lunger John Chief Patient Supply Officer | 2022-01-11 | Sale | −3,770 | $3.56 | $13,409 | 6,343 | D |
| Lunger John Chief Patient Supply Officer | 2022-01-12 | Sale | −1,076 | $3.54 | $3,813 | 1,749 | D |
| Open-market sales · 4,846 sh · avg $3.55 · $17,222 | |||||||
Loading xslF345X03/tm221700-13_4seq1.xml…